Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Transplant nephrology
Would you recommend routinely checking ANCA levels just prior to a planned kidney transplantation in patients with a history of ESKD secondary to ANCA-associated vasculitis?
Related Questions
How do you approach chronic T cell mediated rejection when patient is intolerant to steroids?
When do you recommend genetic testing prior to kidney transplantation for a patient with ESKD secondary to FSGS?
Thoughts about using Fecal transplant as a treatment option for recurrent difficult to treat C diff infection in an elderly kidney transplant patient.
What is your approach to dose adjusting mycophenolate in a kidney transplant recipient who is transitioned from tacrolimus to cyclosporine?
Do you have specific waiting periods before a patient can be listed for a kidney transplant if they have a past history of malignancy?
What are the best practices for preparing blood for transfusion in a patient with a kidney transplant to minimize complications?
Would you proceed with renal transplant in a patient with lupus nephritis who has progressed to ESRD and is clinically stable, but has persistently elevated dsDNA and low complements despite appropriate doses of hydroxychloroquine and mycophenolate?
How have you incorporated donor-derived cell-free DNA to help with the diagnosis of rejection or monitoring of the treatment response to rejection?
How much proteinuria would warrant consideration of native kidney nephrectomies at the time of a kidney transplant?
How do you approach the management of patients with primary membranous nephropathy and a positive anti-PLA2R antibody test who are being considered for kidney transplantation?
